The Patent Finder

MDNA Life Sciences Inc.

4 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4
Ending by 2030
Dec 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 3, 2027
    The maintenance fee for Mitochondrial DNA deletion between about residues 12317-16254 for use in the detection of cancer (US 10,400,290) comes due Mar 3, 2027. Unpaid by Sep 3, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 4 of 4

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,907,213Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
In force
 · USPTO record
In forceUSPTO record
US 10,400,290Mitochondrial DNA deletion between about residues 12317-16254 for use in the detection of cancer
In force
 · USPTO record
In forceUSPTO record
US 10,266,899Aberrant mitochondrial DNA, associated fusion transcripts and hybridization probes therefor
In force
 · USPTO record
In forceUSPTO record
US 8,008,008Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
In force
 · USPTO record
In forceUSPTO record
Also on record, not counted in the 4: 2 lapsed for an unpaid fee · 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 abandoned · 4 no status recorded

Showing 1 to 5 of 5, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
17/415,507Mitochondrial DNA Deletions Associated with EndometriosisDec 20, 2019Abandoned
16/558,108Sep 1, 2019No status recorded
16/386,381Apr 17, 2019No status recorded
16/057,052Aug 7, 2018No status recorded
15/347,601Nov 9, 2016No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited